跳至主要内容
临床试验/CTRI/2025/11/097647
CTRI/2025/11/097647尚未招募不适用

To evaluate the safety and efficacy of a skin care formulation in terms of anti- aging effect that is improvement in skin firmness, skin moisturisation, reduction in wrinkles and fine lines and reduction in dark spot that is age spot on healthy human subjects.

Alvio Pharmaceuticals Pvt Ltd / UNCAP1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2025年11月29日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
36
试验地点
1

研究概览

简要总结

OBJECTIVE:The objective of this study will be to evaluate the safety & efficacy of a Skin care formulation in terms of anti-aging effect i.e. improvement in skin firmness, skin moisturisation, reduction in wrinkles and fine lines & reduction in dark spot (age spot) on healthy human subjects.The evaluation will be performed using:Subject Self Evaluation,Dermatological Evaluation: Cosmetic Acceptability,Dermatological Evaluation: Efficacy,  Cutometry, Corneometry, Mexametry, Digital Photographs

 POPULATION:36 (18 males & 18 females) subjects will be selected for the study.

The subjects selected for this study will be healthy females & males, aged between 35 to 55 years, having crow’s feet wrinkles and dark spot (age spot).

  STUDY DURATION : 56 days following the first application of the product.

研究设计

研究类型
Interventional
分配方式
Na
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
35.00 Year(s) 至 55.00 Year(s)(—)
性别
All

入选标准

  • Indian Male and Female subjects 2)Skin is healthy on the studied anatomic unit 3)Having crows feet wrinkles and dark spot (age spot).

排除标准

  • For Females: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
  • Having refused to give his/her assent by not signing the consent form 3)Taking part in another study liable to interfere with this study 4)Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months) 5)Having acne prone skin.
  • Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 7)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products.
  • Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
  • Having cutaneous hypersensitivity.
  • Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
  • Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit.
  • Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted).

研究者

发起方
Alvio Pharmaceuticals Pvt Ltd / UNCAP
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Niharika Salian

MASCOT-SPINCONTROL India Pvt. Ltd.

研究点 (1)

Loading locations...

相似试验